Nucletron receives FDA clearance for RT viewer

Radiation oncology firm Nucletron has received clearance from the U.S. Food and Drug Administration (FDA) for its radiotherapy (RT) viewer, according to the Veenendaal, Netherlands-based firm.

Oncentra RT Viewer allows users to review and share treatment planning data such as DICOM RT images, RT structure sets, and RT plans, including RT dose, on any computer. It allows digital sharing of plans on the hospital's network or on any other electronic sharing device, the company said.

Related Reading

Nucletron receives Canadian clearance, November 13, 2008

Nucletron debuts gynecology brachytherapy, September 9, 2008

Nucletron taps new CEO, June 30, 2008

Nucletron debuts Oncentra Brachy, June 4, 2008

FDA clears Nucletron's treatment planning product, June 3, 2008

Copyright © 2008

Page 1 of 1234
Next Page